Definitive Healthcare annual r&d spending
2020
2021
2022
2023
2024
2025
Definitive Healthcare R&D Spending Growth & History (DH)
Definitive Healthcare's r&d spending was $34.8M for fiscal 2025.
View full Definitive Healthcare company overviewDefinitive Healthcare annual r&d spending history
| Fiscal year | Period ended | R&D spending | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $34.8M | −$1.7M | −4.77% |
| 2024 | 2024-12-31 | $36.5M | −$5.9M | −13.96% |
| 2023 | 2023-12-31 | $42.4M | $7.6M | +21.64% |
| 2022 | 2022-12-31 | $34.9M | $16.3M | +87.93% |
| 2021 | 2021-12-31 | $18.6M | $7.5M | +67.83% |
| 2020 | 2020-12-31 | $11.1M | — | — |
Definitive Healthcare quarterly r&d spending
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | R&D spending | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $6.8M | −$1.2M | −15.21% |
| Q1 2026 | 2026-03-31 | $6.5M | −$2.8M | −30.13% |
| Q4 2025 | 2025-12-31 | $10.0M | $972,000 | +10.82% |
| Q3 2025 | 2025-09-30 | $7.6M | $271,000 | +3.72% |
| Q2 2025 | 2025-06-30 | $8.0M | −$2.2M | −21.28% |
| Q1 2025 | 2025-03-31 | $9.3M | −$831,000 | −8.20% |
| Q4 2024 | 2024-12-31 | $9.0M | −$2.6M | −22.36% |
| Q3 2024 | 2024-09-30 | $7.3M | −$3.5M | −32.32% |
| Q2 2024 | 2024-06-30 | $10.1M | −$107,000 | −1.05% |
| Q1 2024 | 2024-03-31 | $10.1M | $248,000 | +2.51% |
| Q4 2023 | 2023-12-31 | $11.6M | $1.4M | +14.22% |
| Q3 2023 | 2023-09-30 | $10.8M | $1.6M | +16.88% |
| Q2 2023 | 2023-06-30 | $10.2M | $1.5M | +17.49% |
| Q1 2023 | 2023-03-31 | $9.9M | $3.0M | +44.29% |
| Q4 2022 | 2022-12-31 | $10.1M | $4.4M | +76.22% |
| Q3 2022 | 2022-09-30 | $9.2M | $4.5M | +93.95% |
| Q2 2022 | 2022-06-30 | $8.7M | $4.4M | +103.55% |
| Q1 2022 | 2022-03-31 | $6.8M | $3.1M | +80.55% |
| Q4 2021 | 2021-12-31 | $5.7M | $2.3M | +64.42% |
| Q3 2021 | 2021-09-30 | $4.7M | $2.1M | +81.28% |
| Q2 2021 | 2021-06-30 | $4.3M | $1.8M | +74.07% |
| Q1 2021 | 2021-03-31 | $3.8M | $1.3M | +52.31% |
| Q4 2020 | 2020-12-31 | $3.5M | — | — |
| Q3 2020 | 2020-09-30 | $2.6M | — | — |
| Q2 2020 | 2020-06-30 | $2.5M | — | — |
| Q1 2020 | 2020-03-31 | $2.5M | — | — |
Definitive Healthcare r&d spending trends
Over the last five fiscal years, Definitive Healthcare's r&d spending increased from $11.1M to $34.8M, a change of $23.7M. The latest reported quarter, Q2 2026, shows $6.8M.
About the metric
What research and development spending means
Research and development (R&D) spending covers the costs of creating and improving products, services, software, technologies, and processes. Higher R&D spending may support future innovation, but the amount alone does not show whether those investments will generate returns.
Calculation and source
SEC-reported R&D expense
TickerStat standardizes research and development expense reported in company SEC filings, including the software-specific US-GAAP R&D concept when it is the filer’s primary R&D expense line. It is historical company-reported spending, not an estimate or forecast. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Definitive Healthcare source filings ↗